The global custom synthesis and manufacturing  market was valued at US$271.33 billion in 2022. The  market value is expected to reach US$474.94 billion  by 2028.

Custom Synthesis and Manufacturing (CSM) is on  the rise across the world, driven by strong growth in  end-use demand, innovators shifting focus to core  competencies and outsourcing of production to low  manufacturing cost destinations.

The CSM market is expected to continue to grow  due to the increasing demand for pharmaceuticals,  growing complexity of drugs, advancements in  technology, increasing patent expiry, and growing  trend of green manufacturing. The market is  expected to grow at a CAGR of approx. 10% during  the forecasted period of 2023-2028.

The global custom synthesis and manufacturing  market growth is predicted to be supported by  numerous growth drivers such as the growing  pharmaceutical industry, rising agrochemical  industry growth, surging cases of cancer, escalating  pharma research and development spending,  increasing demand for specialty chemicals,  increasing regulatory compliance requirement,  increasing outsourcing trend, and many other  factors. There are several regulatory compliance  requirements that chemical and drug manufacturers  must follow to ensure the safety and efficacy of their  products.

The market is projected to grow at a fast pace  during the forecast period, due to various latest  trends such as integration of AI/MI, increasing  patent expiry, technological advancement, green  manufacturing, increasing role of automation and  robotics, etc.

The market is projected to grow at a fast pace  during the forecast period, due to various latest  trends such as integration of AI/MI, increasing  patent expiry, technological advancement, green  manufacturing, increasing role of automation and  robotics, etc.

When a drug or chemical’s patent expires, it  opens up opportunities for generic drug  manufacturers and other companies to produce  and sell the same drug or chemical. This often  leads to increased competition, which in turn  drives down the price of the drug or chemical. As  a result, many pharmaceutical and chemical  companies are increasingly turning to custom  synthesis and manufacturing services to reduce  costs and increase efficiency.

Reference:

https://www.globenewswire.com/news-  release/2023/04/26/2654790/0/en/Global-Custom-  Synthesis-Manufacturing-Market-to-2028-  Increasing-Regulatory-Compliance-Requirement-  Fuels-the-Sector.html

https://www.researchandmarkets.com/reports/578  0848/global-custom-synthesis-and-manufacturing-  csm

More News
ECHA Adds Five Hazardous Chemicals To PIC
News · 08/09/2023

The European Chemicals Agency (ECHA) has amended the Prior Informed Consent (PIC) Regulation, EU 64/2012, to add 27 pesticides and eight industrial chemicals into Annex I, bringing the total to 295. As a result, EU exporters are now required to notify their intentions to export them from 1 November onwards.

READ MORE
4 key Trends Reshaping Ocean freight Industry in 2023
News · 04/04/2023

The ocean freight industry is undergoing a massive transformation, as the technology and supply chain management tools are being improved by the day, impacting ocean freight rates.

READ MORE
What do China’s data export regulations mean for its trade competitiveness?
News · 13/12/2022

In the second half of 2022, China unveiled the details of its data export regulations, providing further explanations to its existing laws and regulations on data.

READ MORE
Energy Crisis: The EU Chemical Industry Is Reaching Breaking Point
News · 11/11/2022

The current energy crisis has reached an unsustainable level for the European chemical industry. For the first time ever, the EU imports more chemicals than it exports, both in volume and value, resulting in a trade deficit of € 5.6 bn for the first half of 2022.

READ MORE
European Union proposes to add two new hazard classes to EU CLP regulation for endocrine disruptors (EDCs)
News · 17/10/2022

Endocrine Disrupting Chemicals (also referred to as hormone disruptors or EDCs) are synthetic chemicals that are not produced by the human body and that disrupt the normal functioning of humans and animals.

READ MORE
The Shipping Industry in a downward spiral
News · 03/10/2022

The shipping industry is now returning to normality and is in a downward spiral. The cost of shipping goods from China has slumped to the lowest level in more than two years as the world economy stumbles, dimming prospects for container carriers that turned in record profits during the pandemic.

READ MORE
Global Freight Situation
News · 08/09/2022

No precipitous plunge in container shipping rates, just ‘orderly’ decline.

READ MORE
3 Key Insights into the Global Food and Beverage Market
News · 02/08/2022

The global food and beverage market size is expected to grow from $5.8 trillion in 2021 to $6.4 trillion in 2022 at a growth rate of 9.7%. The food and beverage market size is expected to grow to $8.9 trillion in 2026 at a compound annual growth rate of 8.7%.

READ MORE
NEW DRUGS (AMENDMENT) RULES,2022 MANDATES QR CODES FOR ACTIVE PHARMACEUTICAL INGREDIENTS
News · 01/07/2022

The amendment makes QR codes mandatory on every active pharmaceutical ingredient. The Amendment Rules will come into force from January 01, 2023.

READ MORE